Aim: Malnutrition and inflammation are critical factors affecting the duration of hospitalization. Although the Nutritional Risk Screening 2002 (NRS-2002) is widely recommended for nutritional assessment, its predictive value for length of stay (LOS) remains controversial. The C-reactive protein to albumin ratio (CAR) has emerged as an objective inflammatory-nutritional marker. This study aimed to compare the prognostic performance of NRS-2002 and CAR in predicting prolonged hospitalization in an internal medicine cohort.Methods: This retrospective cohort study included 375 adult patients hospitalized in the internal medicine ward of a tertiary care hospital between April and October 2023. Prolonged LOS was defined as a hospitalization duration exceeding the median value (>9 days). The predictive performance of NRS-2002, albumin, CRP, and CAR was analyzed using univariate and multivariate binary logistic regression and receiver operating characteristic (ROC) curve analysis.Results: The median LOS was 9 days, and 48.8% of patients experienced prolonged hospitalization. In univariate analysis, CAR (8.5 [24.3] vs. 15 [36.9], p=0.004), albumin (3.3 [0.9] vs. 3.0 [0.8] g/dL, p=0.001) and CRP (25.9 [72.5] vs. 46.0 [104.8] mg/L, p=0.008) differed significantly between the normal and prolonged LOS groups. NRS-2002 scores did not differ between groups (3 [2] vs. 3 [2], p=0.617), and nutritional risk prevalence (NRS-2002 ≥3) was identical in both groups (68.3%). ROC analysis showed that CAR (area under the curve [AUC]=0.585) and albumin (AUC=0.604) had superior discriminative ability compared with NRS-2002 (AUC=0.515). In multivariate analysis, CAR remained an independent predictor (odds ratio [OR]=1.01, p=0.038), whereas NRS-2002 was not (p=0.598).Conclusion: CAR index outperforms the NRS-2002 screening tool in predicting prolonged hospital stay in internal medicine inpatients. While NRS-2002 remains essential for identifying patients in need of nutritional intervention, the integration of objective inflammatory-nutritional biomarkers such as CAR may improve risk stratification for hospitalization outcomes.
No takes yet. Share an insight, caveat, or question.
Yesilyurt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: